VEGFA and age-related macular degeneration: Since the approval of anti-vascular endothelial growth factor (VEGF) pharmacotherapy in 2006, the impact on the visual prognosis of AMD has been considerably reduced, removing neovascular AMD from the list of incurable diseases [3].